Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody.
10.1097/CM9.0000000000001235
- Author:
Fei TENG
1
;
Jin-Min PENG
2
;
Qian WANG
3
;
Xin-Lun TIAN
4
;
Zhen HUO
5
;
Li WENG
2
Author Information
1. Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
2. Department of Medical Intensive Care Unit, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
3. Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
4. Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730, Beijing, China.
5. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal, Humanized/therapeutic use*;
Autoantibodies;
Dermatomyositis;
Disease Progression;
Humans;
Lung Diseases, Interstitial/drug therapy*
- From:
Chinese Medical Journal
2020;134(8):999-1000
- CountryChina
- Language:English
